BATS BZX Real-Time Price
As of 10:00am ET
| +0.09 / +1.37%|
The 7 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 3.00. The median estimate represents a +20.12% increase from the last price of 6.66.
The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.